Adaptimmune Therapeutics (ADAP) Technical (Analysis) Reports Adaptimmune Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Adaptimmune Therapeutics (ADAP)
Technical Analysis Report for NASDAQ stock ADAP Adaptimmune Therapeutics. Dated: 24 Feb 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ADAP Adaptimmune Therapeutics then click here. or read Experts views on Adaptimmune Therapeutics or Forecast & share price targets of Adaptimmune Therapeutics
Adaptimmune Therapeutics Opened at 0.56 and Closed at: 0.55, which is -1.82% of previous session's close. It moved within a range of 0.54 and 0.56
The session was a Bearish session with an average volume of 1354500, which is 64.05% of previous session's volumes.
A Dead cross was found 2 days back on short term averages
A Dead cross was found 2 days back on mid term averages
Support for tomorrow is 0.54 and resistance for tomorrow is 0.56
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.54, 0.53 resistance for tomorrow's hourly charts is 0.56, 0.57
10 Day SMA for Adaptimmune Therapeutics (ADAP) is 0.58 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Adaptimmune Therapeutics (ADAP) is 0.59 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Adaptimmune Therapeutics (ADAP) is 0.59 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.68 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Adaptimmune Therapeutics is 0.89 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Adaptimmune Therapeutics is at 0.59 and 200 DMA is at 0.89, while 50 DMA and 100 DMA are at 0.59 and 0.68 respectively
Adaptimmune Therapeutics (ADAP) moving average of 20 SMA is at 0.59 and 20 EMA is at 0.6
| Date | Closing Price | 20 SMA | 20 EMA |
| 24 Mon Feb | 0.55 | 0.59 | 0.6 |
| 21 Fri Feb | 0.56 | 0.59 | 0.6 |
| 20 Thu Feb | 0.58 | 0.59 | 0.6 |
| 19 Wed Feb | 0.58 | 0.59 | 0.6 |
| 19 Wed Feb | 0.58 | 0.59 | 0.6 |
| 18 Tue Feb | 0.58 | 0.59 | 0.6 |
Adaptimmune Therapeutics (ADAP) moving average of 50 SMA is at 0.59 and 50 EMA is at 0.67
| Date | Closing Price | 50 SMA | 50 EMA |
| 24 Mon Feb | 0.55 | 0.59 | 0.67 |
| 21 Fri Feb | 0.56 | 0.59 | 0.67 |
| 20 Thu Feb | 0.58 | 0.59 | 0.67 |
| 19 Wed Feb | 0.58 | 0.59 | 0.67 |
| 19 Wed Feb | 0.58 | 0.6 | 0.67 |
| 18 Tue Feb | 0.58 | 0.6 | 0.67 |
Adaptimmune Therapeutics (ADAP) moving average of 100 SMA is at 0.68 and 100 EMA is at 0.8
| Date | Closing Price | 100 SMA | 100 EMA |
| 24 Mon Feb | 0.55 | 0.68 | 0.8 |
| 21 Fri Feb | 0.56 | 0.69 | 0.8 |
| 20 Thu Feb | 0.58 | 0.69 | 0.8 |
| 19 Wed Feb | 0.58 | 0.7 | 0.8 |
| 19 Wed Feb | 0.58 | 0.7 | 0.8 |
| 18 Tue Feb | 0.58 | 0.7 | 0.8 |
Adaptimmune Therapeutics (ADAP) moving average of 200 SMA is at 0.89 and 200 EMA is at 0.91
| Date | Closing Price | 200 SMA | 200 EMA |
| 24 Mon Feb | 0.55 | 0.89 | 0.91 |
| 21 Fri Feb | 0.56 | 0.9 | 0.91 |
| 20 Thu Feb | 0.58 | 0.9 | 0.91 |
| 19 Wed Feb | 0.58 | 0.9 | 0.91 |
| 19 Wed Feb | 0.58 | 0.9 | 0.91 |
| 18 Tue Feb | 0.58 | 0.91 | 0.91 |
Tonix Pharmaceuticals has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Tonix Pharmaceuticals, about 1813.3% more returns!
Insulet Corporation has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Insulet Corporation, about 9.5% more returns!
Nucana Plc has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Nucana Plc, about 2.11% more returns!
Adaptimmune Therapeutics has performed better than Moderna Inc in short term. Holding Adaptimmune Therapeutics could be a better choice for now!
Adaptimmune Therapeutics has performed better than Moleculin Biotech in short term. Holding Adaptimmune Therapeutics could be a better choice for now!
Adaptimmune Therapeutics has performed better than Leap Therapeutics in short term. Holding Adaptimmune Therapeutics could be a better choice for now!
Krystal Biotech has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Krystal Biotech, about 24.17% more returns!
Kiniksa Pharmaceuticals has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 4.05% more returns!
Adaptimmune Therapeutics has performed better than Ironwood Pharmaceuticals in short term. Holding Adaptimmune Therapeutics could be a better choice for now!
Ionis Pharmaceuticals has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 0.27% more returns!
Henry Schein has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Henry Schein, about 8.8% more returns!
Glycomimetics Inc has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Glycomimetics Inc, about 18.78% more returns!
Galectin Therapeutics has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 25.48% more returns!
Cue Biopharma has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Cue Biopharma, about 1.56% more returns!
Crispr Therapeutics has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 18.16% more returns!
Adaptimmune Therapeutics has performed better than Aptevo Therapeutics in short term. Holding Adaptimmune Therapeutics could be a better choice for now!
Allogene Therapeutics has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 17.66% more returns!
Alkermes Plc has performed better than Adaptimmune Therapeutics in short term. You could have earned much better returns by investing in Alkermes Plc, about 20.44% more returns!
Adaptimmune Therapeutics Technical analysis of indicators
Price action analysis of Adaptimmune Therapeutics (ADAP) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.57 and Adaptimmune Therapeutics ADAP stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics ADAP stock. Volume based technical analysis of Adaptimmune Therapeutics ADAP stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ADAP Adaptimmune Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ADAP Experts View which covers a lot of information including buying and selling signals
ADAP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Adaptimmune Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Adaptimmune Therapeutics (ADAP) Technical (Analysis) Reports Adaptimmune Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance